company background image
A950200 logo

Psomagen KOSDAQ:A950200 Stock Report

Last Price

₩5.30k

Market Cap

₩102.0b

7D

-12.8%

1Y

-16.0%

Updated

27 Mar, 2024

Data

Company Financials

A950200 Stock Overview

Psomagen, Inc. engages in the provision of multi-omics solutions for clinical and research purposes.

A950200 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Psomagen, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Psomagen
Historical stock prices
Current Share Price₩5,300.00
52 Week High₩10,090.00
52 Week Low₩4,550.00
Beta0
1 Month Change6.85%
3 Month Change3.92%
1 Year Change-16.01%
3 Year Change-57.60%
5 Year Changen/a
Change since IPO-64.90%

Recent News & Updates

Recent updates

We're Not Very Worried About Psomagen's (KOSDAQ:950200) Cash Burn Rate

Jan 13
We're Not Very Worried About Psomagen's (KOSDAQ:950200) Cash Burn Rate

Shareholder Returns

A950200KR BiotechsKR Market
7D-12.8%3.1%3.8%
1Y-16.0%23.4%13.0%

Return vs Industry: A950200 underperformed the KR Biotechs industry which returned 23.4% over the past year.

Return vs Market: A950200 underperformed the KR Market which returned 13% over the past year.

Price Volatility

Is A950200's price volatile compared to industry and market?
A950200 volatility
A950200 Average Weekly Movement8.3%
Biotechs Industry Average Movement7.9%
Market Average Movement5.3%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A950200 has not had significant price volatility in the past 3 months.

Volatility Over Time: A950200's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004n/an/ahttps://www.psomagen.com

Psomagen, Inc. engages in the provision of multi-omics solutions for clinical and research purposes. The company provides genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its expression through sequencing, offered to analyze the impact of gene expression on the biology of an organism; and proteomics, a study of all the expressed proteins in an organism (proteome). It also offers Bioinformatics, a software tool and pipeline that helps scientists in analyzing data, as well as provides clinical testing solutions.

Psomagen, Inc. Fundamentals Summary

How do Psomagen's earnings and revenue compare to its market cap?
A950200 fundamental statistics
Market cap₩101.95b
Earnings (TTM)₩0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A950200 income statement (TTM)
Revenue₩0
Cost of Revenue₩0
Gross Profit₩0
Other Expenses₩0
Earnings₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did A950200 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.